CD8A and breast neoplasm: We also demonstrate for the first time that IL-15SA/IL-15RαSu-Fc exhibited potent anti-metastatic activity, dependent on CD8+ T and NK cells, and prolonged the survival of mice, initially in the 4T1 breast tumor model, which resembles advanced breast cancer in humans (Figure 7).